MDA-MB-231 tumor-bearing mice with or without HuR CRISPR knockout were constructed to assess the in vivo antitumor efficacy of various DTX formulations (5 mg/kg body weight of DTX). The gene discussed is ELAVL1; the disease is neoplasm.